In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Helen E. Heslop

SPORE in Lymphoma

Leukaemia Non-Hodgkin lymphoma

Hematology and hematologic malignancies

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

Myeloproliferative Disorders (MPD) Research Consortium

Leukaemia

Hematology and hematologic malignancies

Targeting BCL6 in Tyrosine Kinase-Driven Leukemia

Leukaemia

Hematology and hematologic malignancies

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Leukaemia Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Hematology and hematologic malignancies

Rainer F Storb

Hematopoietic Chimerism after Stem Cell Allografts

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies

Corey Casper

Burkitt Lymphoma Trials Network (BLTN)

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Michele S Redell

Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML

Leukaemia

Hematology and hematologic malignancies